KOD
Price
$87.63
Change
+$1.85 (+2.16%)
Updated
Oct 23 closing price
Capitalization
5.51B
19 days until earnings call
Intraday BUY SELL Signals
VRCA
Price
$3.53
Change
-$0.30 (-7.83%)
Updated
Oct 23 closing price
Capitalization
60.64M
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KOD vs VRCA

KOD vs VRCA Comparison Chart in %
View a ticker or compare two or three
VS
KOD vs. VRCA commentary
Oct 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Hold and VRCA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for KOD with price predictions
Oct 23, 2026

KOD in upward trend: price rose above 50-day moving average on September 28, 2026

KOD moved above its 50-day moving average on September 28, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 55 cases where KOD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The 10-day moving average for KOD crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.

Following a +8.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where KOD advanced for three days, in 229 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

The 10-day RSI Indicator for KOD moved out of overbought territory on October 13, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 30 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KOD as a result. In 58 of 68 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for KOD turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 33 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KOD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

KOD broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for KOD entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. KOD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: KOD's P/B Ratio (90.145) is slightly higher than the industry average of (3.043). P/E Ratio (-20.914) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KOD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for VRCA with price predictions
Oct 23, 2026

VRCA's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for VRCA moved out of oversold territory on October 21, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In 32 of the 35 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 66 cases where VRCA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

Following a +10.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where VRCA advanced for three days, in 223 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

VRCA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VRCA as a result. In 85 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for VRCA turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 40 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VRCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for VRCA entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.080) is normal, around the industry mean (3.035). P/E Ratio (-2.029) is within average values for comparable stocks, (-1.360). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (2.496) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. VRCA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VRCA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
KOD vs VRCA: Fundamental Ratings
KOD
VRCA
OUTLOOK RATING
1..100
4650
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3483
P/E GROWTH RATING
1..100
9713
SEASONALITY SCORE
1..100
18n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VRCA's Valuation (82) in the Pharmaceuticals Major industry is in the same range as KOD (95) in the Biotechnology industry. This means that VRCA’s stock grew similarly to KOD’s over the last 12 months.

VRCA's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as KOD (100) in the Biotechnology industry. This means that VRCA’s stock grew similarly to KOD’s over the last 12 months.

VRCA's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as KOD (100) in the Biotechnology industry. This means that VRCA’s stock grew similarly to KOD’s over the last 12 months.

KOD's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for VRCA (83) in the Pharmaceuticals Major industry. This means that KOD’s stock grew somewhat faster than VRCA’s over the last 12 months.

VRCA's P/E Growth Rating (13) in the Pharmaceuticals Major industry is significantly better than the same rating for KOD (97) in the Biotechnology industry. This means that VRCA’s stock grew significantly faster than KOD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODVRCA
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 25, 2026
Stock price -- (KOD: $87.63 vs. VRCA: $3.53)
Brand notoriety: KOD and VRCA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 24% vs. VRCA: 22%
Market capitalization -- KOD: $5.51B vs. VRCA: $60.64M
KOD [@Biotechnology] is valued at $5.51B. VRCA’s [@Biotechnology] market capitalization is $60.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.8B. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 0 FA rating(s) are green while VRCA’s FA Score has 1 green FA rating(s).

  • KOD’s FA Score: 0 green, 5 red.
  • VRCA’s FA Score: 1 green, 4 red.
According to our system of comparison, both KOD and VRCA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 4 TA indicator(s) are bullish while VRCA’s TA Score has 4 bullish TA indicator(s).

  • KOD’s TA Score: 4 bullish, 6 bearish.
  • VRCA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VRCA is a better buy in the short-term than KOD.

Price Growth

KOD (@Biotechnology) experienced а +2.19% price change this week, while VRCA (@Biotechnology) price change was -1.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.

Reported Earning Dates

KOD is expected to report earnings on Nov 12, 2026.

VRCA is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
KOD
Daily Signal:
Gain/Loss:
VRCA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WISE31.760.50
+1.61%
Themes Generative Artificial Intelligence ETF (WISE)
DSL9.780.01
+0.10%
DOUBLELINE Income SOLUTIONS FUND
MHIG19.94N/A
N/A
Milliman Healthcare Inflation Guard ETF (MHIG)
AFGR36.56-0.06
-0.15%
First Trust Active Factor Large Cap Growth ETF (AFGR)
MFUS65.33-0.48
-0.73%
PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF (MFUS)

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with RZLT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then RZLT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+2.16%
RZLT - KOD
36%
Loosely correlated
-0.13%
VCYT - KOD
34%
Loosely correlated
+4.11%
MLTX - KOD
34%
Loosely correlated
-3.97%
ENTA - KOD
31%
Poorly correlated
+0.17%
SION - KOD
31%
Poorly correlated
-5.26%
More